Lexicon Pharmaceuticals LXRX Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationOtherAdjustments.
The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount?
- Lexicon Pharmaceuticals (LXRX) reported effective income tax rate reconciliation, other adjustments, amount of $48.75K in Q4 2025.
- How has Lexicon Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount changed year-over-year?
- Lexicon Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount decreased by 57.0% year-over-year, from $113.5K to $48.75K.
- What is the long-term trend for Lexicon Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's effective income tax rate reconciliation, other adjustments, amount has grown at a -14.7% compound annual growth rate (CAGR), from $368K to $195K.